Drug Name |
Bedaquiline |
Drug ID |
BADD_D00221 |
Description |
Bedaquiline is a bactericidal antimycobacterial drug. Chemically it is a diarylquinoline. FDA approved on December 28, 2012. |
Indications and Usage |
Bedaquiline is indicated as part of combination therapy in adults (≥ 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB). |
Marketing Status |
Prescription |
ATC Code |
J04AK05 |
DrugBank ID |
DB08903
|
KEGG ID |
D09872
|
MeSH ID |
C493870
|
PubChem ID |
5388906
|
TTD Drug ID |
D0Y4QG
|
NDC Product Code |
Not Available |
Synonyms |
bedaquiline | (1R,2S)-1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(3-fluorophenyl)-1-phenyl-butan-2-ol | R207910 | TMC207 | AIDS222088 | AIDS-222089 | bedaquiline fumarate |